Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxybenzone is an organic compound and a derivative of benzophenone, widely used as a sunscreen agent in topical formulations. It functions by absorbing ultraviolet (UV) radiation, particularly UV-A rays, thereby preventing them from penetrating the skin and causing damage such as sunburn or premature aging. Oxybenzone is also used in various cosmetics and personal care products for its photoprotective properties. Its mechanism of action involves ultrafast energy dissipation after UVA irradiation, which helps protect skin cells from UV-induced harm[1][4][8]. The compound has been under scrutiny due to environmental concerns—especially its toxicity to coral reefs—and potential safety issues for humans[6]. Oxybenzone was first synthesized in Germany in the early twentieth century[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Oxybenzone.